| 18.42 -0.21 (-1.13%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 22.27 | 1-year : | 23.78 |
| Resists | First : | 19.06 | Second : | 20.36 |
| Pivot price | 18.88  |
|||
| Supports | First : | 16.97 | Second : | 14.12 |
| MAs | MA(5) : | 18.56  |
MA(20) : | 19 |
| MA(100) : | 16.2 |
MA(250) : | 13.87 |
|
| MACD | MACD : | 0 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 49.7 |
D(3) : | 51.8 |
| RSI | RSI(14): 47.4 |
|||
| 52-week | High : | 20.36 | Low : | 9.71 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CLB ] has closed above bottom band by 25.4%. Bollinger Bands are 37.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 18.62 - 18.71 | 18.71 - 18.79 |
| Low: | 17.8 - 17.89 | 17.89 - 17.97 |
| Close: | 18.27 - 18.43 | 18.43 - 18.56 |
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Sat, 14 Feb 2026
Core Laboratories (NYSE:CLB) Shares Pass Above 200 Day Moving Average - Should You Sell? - MarketBeat
Thu, 05 Feb 2026
Core Lab (CLB) Q4 2025 Earnings Call Transcript - AOL.com
Thu, 05 Feb 2026
Core Laboratories Balances Revenue Growth and Margin Pressure - TipRanks
Thu, 05 Feb 2026
Earnings call transcript: Core Laboratories Q4 2025 earnings miss forecasts - Investing.com
Thu, 05 Feb 2026
Core Laboratories Inc. (NYSE:CLB) Declares Quarterly Dividend of $0.01 - MarketBeat
Wed, 04 Feb 2026
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Energy
|
|
|
Industry:
Oil & Gas Equipment & Services
|
|
| Shares Out | 47 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 115.1 (%) |
| Shares Short | 4,030 (K) |
| Shares Short P.Month | 4,270 (K) |
| EPS | 0.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.88 |
| Profit Margin | 6.2 % |
| Operating Margin | 11.9 % |
| Return on Assets (ttm) | 4.9 % |
| Return on Equity (ttm) | 12.2 % |
| Qtrly Rev. Growth | 0.1 % |
| Gross Profit (p.s.) | 2.21 |
| Sales Per Share | 11.11 |
| EBITDA (p.s.) | 1.33 |
| Qtrly Earnings Growth | 20 % |
| Operating Cash Flow | 50 (M) |
| Levered Free Cash Flow | 41 (M) |
| PE Ratio | 27.08 |
| PEG Ratio | 0 |
| Price to Book value | 3.12 |
| Price to Sales | 1.65 |
| Price to Cash Flow | 17.25 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|